姓名

林庭安

學歷

國立陽明交通大學醫學系醫學士

國立陽明交通大學醫學院生理學科暨研究所博士候選人

經歷

臺北榮總內科部住院醫師

臺北榮總內科部血液科住院總醫師

臺北榮總腫瘤醫學部藥物治療科住院總醫師

現職

臺北榮總內科部血液科主治醫師 (2020.7.1起，迄今)

專長

血液學、貧血、血小板及凝血病變、淋巴癌、血癌、骨髓瘤、造血幹細胞移植

教職

部定國立陽明交通大學醫學院內科學科講師

專科醫師

資格

內科專科醫師
血液專科醫師
腫瘤內科專科醫師
血液及骨髓移植專科醫師

代表著作

1. Lin TA, Yang CF, Liu YC, Liu JH, Chiou TJ, Hsiao LT, Yen HJ, Liu CJ, Wang HY, Ko PS, Chien SH, Gau JP. Hematopoietic stem cell transplantation for subcutaneous panniculitis-like T-cell lymphoma: single center experience in an Asian population. Int J Hematol. 2019 Feb;109(2):187-196.
2. Lin TA, Gau JP, Liu YC, Ko PS, Wang HY, Chien SH, Liu CJ, Hsiao LT, Chiou TJ, Liu JH. Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome. Int J Hematol. 2019 May; 109(5): 584-592.  
3. Tu PS, Lin EC, Chen HW, Chen SW, Lin TA, Gau JP, Chang YI. The extracellular signal-regulated kinase 1/2 modulates the intracellular localization of DNA methyltransferase 3A to regulate erythrocytic differentiation. Am J Transl Res. 2020 Mar 15;12(3):1016-1030.
4. Liu YC, Lin TA, Wang HY, Ko PS, Liu CJ, Hsiao LT, Chien SH, Gau JP. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report. J Med Case Rep. 2020 Mar 17;14(1):43.
5. Lin EC, Chen SW, Chen LK, Lin TA, Wu YX, Juan CC, Chang YI. Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells. Front Nutr. 2021 Nov 10;8:762363.